Latest Financial Health News

Aurelia Metals has successfully met its FY25 production guidance across all key metals while strengthening its cash position to A$110 million, setting the stage for upcoming growth projects including the Great Cobar development.

Manuka Resources Ltd has been reinstated to ASX trading following the announcement of a proposed material capital raising, signaling renewed investor interest.

SDI Limited reports a flat sales performance for FY25 with regional growth offset by declines in key markets, while advancing its Montrose facility project with funding plans underway.

Cobram Estate Olives has reported a record 2025 Australian olive harvest with a 10.2% increase in production and forecasts a strong FY2025 EBITDA of $115 million. The company also announces strategic moves including a CEO relocation to the US and acquisition of farming machinery business Leda Ag.

Australian Pacific Coal Limited has voluntarily suspended trading following the appointment of administrators and receivers at its Dartbrook Mine operator entities, signaling significant financial distress within the joint venture.

RPMGlobal reports a strong 30.9% rise in software sales for FY2025, driven by subscription growth, with recurring revenue and backlog reaching new highs.

AMP Limited is set to defend itself against a new class action alleging inflated life insurance premiums and a separate dispute over a major property sale, signaling potential challenges ahead for the financial services giant.

US Masters Residential Property Group has announced a special distribution of 10 cents per stapled security, payable in early August 2025. Investors should note key dates for eligibility and payment.

NT Minerals has agreed to sell its Redbank and Wollogorang copper projects to Golden Horse Minerals for $3 million in combined cash and equity, shifting its strategic focus to other critical mineral assets.

Keybridge Capital has obtained a $9.3 million bridge funding facility from Active Asset Management, supported by an ASX waiver allowing the deal without prior shareholder approval. The funding aims to address urgent liquidity and solvency challenges while trading remains suspended.

Findi Limited will have its trading suspension lifted on 2 July 2025 following the lodgement of its 2025 annual report, reopening its shares to market activity.

The Reject Shop Limited has received Federal Court approval for its Scheme, enabling a fully franked special dividend of AUD 0.77 per share payable mid-July.